Researchers at MIT have developed novel antibiotics using generative AI to combat drug-resistant infections. The AI algorithms designed and screened over 36 million compounds, identifying candidates structurally distinct from existing antibiotics. These compounds disrupt bacterial cell membranes, offering a new approach to fighting infections.
The AI used two approaches: designing molecules based on a specific chemical fragment with antimicrobial activity and freely generating molecules without a specific fragment. This led to the discovery of potential drugs effective against Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). The AI's ability to explore vast chemical spaces has opened new possibilities for antibiotic development.
With drug-resistant bacterial infections causing nearly 5 million deaths annually, this AI-driven approach offers a promising solution. The researchers hope to apply this strategy to identify compounds effective against other bacterial species, potentially revitalising the antibiotic pipeline.
Subscribe for Weekly Updates
Stay ahead with our weekly AI and tech briefings, delivered every Tuesday.
